OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of non-classical MHC class I molecules in cancer immunosuppression
Grazyna Kochan, David Escors, Karine Breckpot, et al.
OncoImmunology (2013) Vol. 2, Iss. 11, pp. e26491-e26491
Open Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
Malte Mohme, Sabine Riethdorf, Klaus Pantel
Nature Reviews Clinical Oncology (2016) Vol. 14, Iss. 3, pp. 155-167
Closed Access | Times Cited: 529

Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
Leisha A. Emens, Paolo A. Ascierto, Phillip K. Darcy, et al.
European Journal of Cancer (2017) Vol. 81, pp. 116-129
Closed Access | Times Cited: 506

Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition
Branca Pereira, Oliver Devine, Milica Vukmanovic‐Stejic, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 406

The immunology of renal cell carcinoma
C. Marcela Díaz‐Montero, Brian I. Rini, James H. Finke
Nature Reviews Nephrology (2020) Vol. 16, Iss. 12, pp. 721-735
Closed Access | Times Cited: 343

Selenium‐Containing Nanoparticles Combine the NK Cells Mediated Immunotherapy with Radiotherapy and Chemotherapy
Shiqian Gao, Tianyu Li, Ye Guo, et al.
Advanced Materials (2020) Vol. 32, Iss. 12
Closed Access | Times Cited: 243

Immunotherapy in Lung Cancer: Current Landscape and Future Directions
Hirva Mamdani, Sandro Matosevic, Ahmed Bilal Khalid, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 217

In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer
Juan Dubrot, Peter P. Du, Sarah Kate Lane-Reticker, et al.
Nature Immunology (2022) Vol. 23, Iss. 10, pp. 1495-1506
Closed Access | Times Cited: 124

Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
Darel Martínez Bedoya, Valérie Dutoit, Denis Migliorini
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 111

Symphony of nanomaterials and immunotherapy based on the cancer–immunity cycle
Qianqian Li, Zhaoqing Shi, Fan Zhang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 1, pp. 107-134
Open Access | Times Cited: 111

Clinical Role of Human Leukocyte Antigen in Health and Disease
Youssef M. Mosaad
Scandinavian Journal of Immunology (2015) Vol. 82, Iss. 4, pp. 283-306
Open Access | Times Cited: 174

Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells
Elliott J. Brea, Claire Y. Oh, Eusebio Manchado, et al.
Cancer Immunology Research (2016) Vol. 4, Iss. 11, pp. 936-947
Open Access | Times Cited: 157

Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy
Aifen Lin, Wei‐Hua Yan
Molecular Medicine (2015) Vol. 21, Iss. 1, pp. 782-791
Open Access | Times Cited: 120

Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation
Cristina Grange, Marta Tapparo, Stefania Tritta, et al.
BMC Cancer (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 112

Trial Watch: Peptide-based anticancer vaccines
Jonathan Pol, Norma Bloy, Aitziber Buqué, et al.
OncoImmunology (2015) Vol. 4, Iss. 4, pp. e974411-e974411
Open Access | Times Cited: 108

Harnessing the immune system in acute myeloid leukaemia
Rebecca Austin, Mark J. Smyth, Steven Lane
Critical Reviews in Oncology/Hematology (2016) Vol. 103, pp. 62-77
Closed Access | Times Cited: 102

HLA and proteasome expression body map
Sebastian Boegel, Martin Löwer, Thomas Bukur, et al.
BMC Medical Genomics (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 100

Immune evasion by cancer stem cells
Hiroyuki Tsuchiya, Goshi Shiota
Regenerative Therapy (2021) Vol. 17, pp. 20-33
Open Access | Times Cited: 94

Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
Vincent Yi Sheng Oei, Marta Siernicka, Agnieszka Graczyk‐Jarzynka, et al.
Cancer Immunology Research (2018) Vol. 6, Iss. 4, pp. 467-480
Open Access | Times Cited: 90

NKG2A, a New Kid on the Immune Checkpoint Block
John B.A.G. Haanen, Vincenzo Cerundolo
Cell (2018) Vol. 175, Iss. 7, pp. 1720-1722
Open Access | Times Cited: 89

The Role of Antigen Processing and Presentation in Cancer and the Efficacy of Immune Checkpoint Inhibitor Immunotherapy
Anastasia Mpakali, Efstratios Stratikos
Cancers (2021) Vol. 13, Iss. 1, pp. 134-134
Open Access | Times Cited: 89

The Immune Microenvironment and Cancer Metastasis
Asmaa El-Kenawi, Kay Hänggi, Brian Ruffell
Cold Spring Harbor Perspectives in Medicine (2019) Vol. 10, Iss. 4, pp. a037424-a037424
Open Access | Times Cited: 85

Cancer-Associated Angiogenesis: The Endothelial Cell as a Checkpoint for Immunological Patrolling
Antonio Giovanni Solimando, Simona De Summa, Angelo Vacca, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3380-3380
Open Access | Times Cited: 84

Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond
Simona Pagliuca, Carmelo Gurnari, Marie Thérèse Rubio, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40

Senescent T cells: Beneficial and detrimental roles
Phatthamon Laphanuwat, Daniel Cláudio Oliveira Gomes, Arne N. Akbar
Immunological Reviews (2023) Vol. 316, Iss. 1, pp. 160-175
Open Access | Times Cited: 22

Page 1 - Next Page

Scroll to top